Analyst Consensus ?
ConsensusBuy45 ratings
Bullish3373.3%
Neutral1226.7%
Bearish00.0%
FN2 Earnings Intelligence
AutoZone, Inc. complete analyst coverage
AutoZone, Inc. (AZO) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$3,142.17Current
$1,490Low
$3,466.41Average
$4,800High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Jun 4, 2026 |
| Citigroup | Buy | Buy | Maintain | May 28, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 27, 2026 |
| Roth Capital | Buy | Buy | Maintain | May 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 27, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 27, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 27, 2026 |
| DA Davidson | Buy | Buy | Maintain | May 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | May 27, 2026 |
| Baird | Neutral | Neutral | Maintain | May 27, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Mar 10, 2026 |
| Argus Research | Buy | Hold | Upgrade | Mar 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Mar 4, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jan 8, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 16, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Dec 10, 2025 |
| UBS | Buy | Buy | Maintain | Dec 10, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Nov 13, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Sep 24, 2025 |
| B of A Securities | Buy | Neutral | Upgrade | May 21, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Mar 5, 2025 |
| Roth MKM | Buy | Buy | Maintain | Mar 5, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Dec 6, 2023 |
| Jefferies | Buy | Buy | Maintain | Sep 20, 2022 |
| MKM Partners | Buy | Buy | Maintain | Jun 23, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Sep 22, 2021 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 26, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Sep 8, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | May 27, 2020 |
| Nomura | Buy | Buy | Maintain | May 27, 2020 |
| CFRA | Buy | Strong Buy | Downgrade | May 26, 2020 |
| Citi | Buy | Buy | Maintain | Sep 13, 2019 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 27, 2019 |
| Argus | Buy | Buy | Maintain | Dec 6, 2018 |
| Bank of America | Neutral | Buy | Downgrade | Sep 17, 2018 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Dec 4, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Aug 25, 2016 |
| BTIG Research | Buy | Buy | Maintain | Jun 1, 2016 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 15, 2016 |
| Sterne Agee | Neutral | Underperform | Upgrade | Mar 4, 2015 |
| William Blair | Perform | Market Perform | Maintain | Sep 30, 2014 |
| Argus Capital | Hold | Buy | Downgrade | Sep 25, 2014 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jul 18, 2014 |
| Stifel | Hold | Buy | Downgrade | Jul 18, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $3,142.17. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Scot Ciccarelli | $3,817 | $3,058.79 | +21.5% | May 27, 2026 |
| Truist Financial | Analyst unavailable | $3,700 | $3,068.6 | +17.8% | May 27, 2026 |
| D.A. Davidson | Michael Baker | $3,750 | $2,999.47 | +19.3% | May 27, 2026 |
| Roth Capital | Analyst unavailable | $4,023 | $3,100.11 | +28.0% | May 27, 2026 |
| Morgan Stanley | Analyst unavailable | $3,605 | $3,100.11 | +14.7% | May 27, 2026 |
| Guggenheim | Analyst unavailable | $4,000 | $3,100.11 | +27.3% | May 27, 2026 |
| BMO Capital | Analyst unavailable | $4,000 | $3,100.11 | +27.3% | May 27, 2026 |
| Mizuho Securities | Analyst unavailable | $3,200 | $3,100.11 | +1.8% | May 27, 2026 |
| Robert W. Baird | Analyst unavailable | $3,600 | $3,100.11 | +14.6% | May 27, 2026 |
| Argus Research | Analyst unavailable | $4,325 | $3,672.68 | +37.6% | Mar 9, 2026 |
| D.A. Davidson | Michael Baker | $4,300 | $3,742.02 | +36.8% | Mar 5, 2026 |
| Mizuho Securities | David Bellinger | $3,600 | $3,694.41 | +14.6% | Mar 5, 2026 |
| Truist Financial | Scot Ciccarelli | $4,045 | $3,663.82 | +28.7% | Mar 4, 2026 |
| UBS | Analyst unavailable | $4,800 | $3,637.17 | +52.8% | Mar 3, 2026 |
| D.A. Davidson | Michael Baker | $4,100 | $3,675.79 | +30.5% | Mar 3, 2026 |
| Robert W. Baird | Analyst unavailable | $3,900 | $3,681.26 | +24.1% | Feb 9, 2026 |
| UBS | Michael Lasser | $4,555 | $3,763.27 | +45.0% | Feb 4, 2026 |
| Morgan Stanley | Simeon Gutman | $4,000 | $3,472.66 | +27.3% | Jan 15, 2026 |
| Barclays | Analyst unavailable | $3,880 | $3,318.08 | +23.5% | Jan 8, 2026 |
| Mizuho Securities | David Bellinger | $3,550 | $3,303.82 | +13.0% | Jan 5, 2026 |
| Truist Financial | Scot Ciccarelli | $4,076 | $3,415.43 | +29.7% | Dec 10, 2025 |
| Jefferies | Bret Jordan | $4,400 | $3,428.95 | +40.0% | Dec 10, 2025 |
| Roth Capital | Scott Stember | $4,650 | $3,390 | +48.0% | Dec 10, 2025 |
| D.A. Davidson | Michael Baker | $4,500 | $3,405.34 | +43.2% | Dec 10, 2025 |
| Mizuho Securities | Analyst unavailable | $3,850 | $3,394.07 | +22.5% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $4,400 | $3,493.36 | +40.0% | Dec 10, 2025 |
| BMO Capital | Analyst unavailable | $4,400 | $3,493.36 | +40.0% | Dec 10, 2025 |
| UBS | Analyst unavailable | $4,325 | $3,493.36 | +37.6% | Dec 10, 2025 |
| Wells Fargo | Zachary Fadem | $4,500 | $3,493.36 | +43.2% | Dec 10, 2025 |
| Barclays | Analyst unavailable | $4,318 | $3,493.36 | +37.4% | Dec 10, 2025 |
| Evercore ISI | Greg Melich | $4,100 | $3,493.36 | +30.5% | Dec 10, 2025 |
| Robert W. Baird | Justin Kleber | $4,500 | $3,822.92 | +43.2% | Dec 3, 2025 |
| D.A. Davidson | Michael Baker | $4,850 | $3,680.24 | +54.4% | Nov 6, 2025 |
| BMO Capital | Tristan Thomas-Martin | $4,600 | $4,147.26 | +46.4% | Sep 25, 2025 |
| Raymond James | Bobby Griffin | $4,800 | $4,090.48 | +52.8% | Sep 24, 2025 |
| Morgan Stanley | Simeon Gutman | $4,700 | $4,099.32 | +49.6% | Sep 24, 2025 |
| Wells Fargo | Zachary Fadem | $4,700 | $4,120 | +49.6% | Sep 24, 2025 |
| Evercore ISI | Greg Melich | $4,500 | $4,166.32 | +43.2% | Sep 18, 2025 |
| Wolfe Research | Analyst unavailable | $4,741 | $4,232.57 | +50.9% | Sep 17, 2025 |
| Truist Financial | Analyst unavailable | $4,504 | $4,232.57 | +43.3% | Sep 17, 2025 |
| Roth Capital | Scott Stember | $4,135 | $3,749.81 | +31.6% | Jun 2, 2025 |
| Truist Financial | Scot Ciccarelli | $3,995 | $3,829.93 | +27.1% | May 23, 2025 |
| Evercore ISI | Greg Melich | $3,950 | $3,879.97 | +25.7% | May 19, 2025 |
| BMO Capital | Analyst unavailable | $3,850 | $3,555.88 | +22.5% | Mar 5, 2025 |
| D.A. Davidson | Analyst unavailable | $3,500 | $3,555.88 | +11.4% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $3,850 | $3,555.88 | +22.5% | Mar 5, 2025 |
| Roth Capital | Analyst unavailable | $3,763 | $3,555.88 | +19.8% | Mar 5, 2025 |
| Raymond James | Analyst unavailable | $4,000 | $3,555.88 | +27.3% | Mar 5, 2025 |
| Wells Fargo | Analyst unavailable | $3,850 | $3,555.88 | +22.5% | Mar 5, 2025 |
| UBS | Analyst unavailable | $4,025 | $3,555.88 | +28.1% | Mar 5, 2025 |
| Argus Research | Bill Selesky | $3,678 | $3,250 | +17.1% | Jan 2, 2025 |
| BMO Capital | Tristan Thomas-Martin | $3,700 | $3,370.27 | +17.8% | Dec 13, 2024 |
| Evercore ISI | Greg Melich | $3,450 | $3,342.72 | +9.8% | Dec 11, 2024 |
| Truist Financial | Scot Ciccarelli | $3,753 | $3,342.72 | +19.4% | Dec 11, 2024 |
| UBS | Michael Lasser | $3,875 | $3,342.72 | +23.3% | Dec 11, 2024 |
| Wells Fargo | Zachary Fadem | $3,750 | $3,342.72 | +19.3% | Dec 11, 2024 |
| Evercore ISI | Greg Melich | $3,390 | $3,337.23 | +7.9% | Dec 9, 2024 |
| Roth Capital | Scott Stember | $3,634 | $3,100 | +15.7% | Oct 16, 2024 |
| Goldman Sachs | Kate McShane | $2,917 | $3,129.78 | -7.2% | Oct 14, 2024 |
| Argus Research | Bill Selesky | $3,560 | $3,189.33 | +13.3% | Sep 27, 2024 |
| Truist Financial | Scot Ciccarelli | $3,341 | $3,051.15 | +6.3% | Sep 25, 2024 |
| Mizuho Securities | David Bellinger | $3,350 | $3,043.97 | +6.6% | Sep 25, 2024 |
| Citigroup | Steven Zaccone | $3,500 | $3,043.97 | +11.4% | Sep 25, 2024 |
| CFRA | Garrett Nelson | $3,300 | $3,036.18 | +5.0% | Sep 24, 2024 |
| Oppenheimer | Brain Nagel | $2,600 | $3,031.42 | -17.3% | Sep 20, 2024 |
| Evercore ISI | Greg Melich | $3,350 | $3,040.09 | +6.6% | Sep 20, 2024 |
| Barclays | Matthew McClintock | $3,024 | $3,123.36 | -3.8% | Sep 16, 2024 |
| Evercore ISI | Greg Melich | $3,278 | $2,940.11 | +4.3% | Jun 27, 2024 |
| Cowen & Co. | Max Rakhlenko | $3,450 | $2,763.55 | +9.8% | Jun 6, 2024 |
| Truist Financial | Scot Ciccarelli | $3,394 | $2,800.01 | +8.0% | May 22, 2024 |
| UBS | Michael Lasser | $3,340 | $2,820.83 | +6.3% | May 22, 2024 |
| Morgan Stanley | Simeon Gutman | $3,038 | $2,820.83 | -3.3% | May 22, 2024 |
| Wolfe Research | Chris Bottiglieri | $3,000 | $2,820.83 | -4.5% | May 22, 2024 |
| Evercore ISI | Greg Melich | $3,250 | $2,820.83 | +3.4% | May 22, 2024 |
| CFRA | Garrett Nelson | $3,250 | $2,834.66 | +3.4% | May 21, 2024 |
| Goldman Sachs | Kate McShane | $3,000 | $2,677.85 | -4.5% | Dec 5, 2023 |
| Truist Financial | Scot Ciccarelli | $2,933 | $2,618.57 | -6.7% | Dec 1, 2023 |
| Morgan Stanley | Simeon Gutman | $2,750 | $2,577.02 | -12.5% | Sep 20, 2023 |
| D.A. Davidson | Michael Baker | $2,340 | $2,535.29 | -25.5% | Sep 18, 2023 |
| UBS | Michael Lasser | $2,900 | $2,493.83 | -7.7% | Jun 16, 2023 |
| Evercore ISI | Greg Melich | $2,700 | $2,399.11 | -14.1% | Jun 12, 2023 |
| Barclays | Analyst unavailable | $2,663 | $2,419.81 | -15.2% | Feb 8, 2023 |
| Raymond James | Bobby Griffin | $2,600 | $2,465.89 | -17.3% | Dec 7, 2022 |
| Truist Financial | Analyst unavailable | $2,800 | $2,482.04 | -10.9% | Dec 7, 2022 |
| UBS | Analyst unavailable | $2,540 | $2,449.79 | -19.2% | Dec 7, 2022 |
| Wells Fargo | Analyst unavailable | $2,850 | $2,545.98 | -9.3% | Nov 29, 2022 |
| Stephens | Daniel Imbro | $2,400 | $2,243.65 | -23.6% | Oct 5, 2022 |
| Argus Research | Analyst unavailable | $2,330 | $2,111.42 | -25.8% | Sep 27, 2022 |
| Truist Financial | Analyst unavailable | $2,292 | $2,117.34 | -27.1% | Sep 20, 2022 |
| J.P. Morgan | Christopher Horvers | $2,450 | $2,097.59 | -22.0% | Sep 20, 2022 |
| Jefferies | Analyst unavailable | $2,450 | $2,114.68 | -22.0% | Sep 20, 2022 |
| J.P. Morgan | Analyst unavailable | $2,660 | $2,114.68 | -15.3% | Sep 20, 2022 |
| Wedbush | Analyst unavailable | $2,350 | $2,101.21 | -25.2% | Sep 20, 2022 |
| Citigroup | Analyst unavailable | $2,520 | $2,114 | -19.8% | Sep 20, 2022 |
| UBS | Analyst unavailable | $2,260 | $2,216.56 | -28.1% | Sep 12, 2022 |
| Wells Fargo | Analyst unavailable | $2,450 | $2,198.74 | -22.0% | Sep 9, 2022 |
| Raymond James | Analyst unavailable | $2,350 | $2,224.32 | -25.2% | Jul 20, 2022 |
| MKM Partners | David Bellinger | $2,350 | $2,159.81 | -25.2% | Jul 2, 2022 |
| Goldman Sachs | Kate McShane | $2,296 | $2,159.81 | -26.9% | Jul 2, 2022 |
| Goldman Sachs | Kate McShane | $2,296 | $2,169.27 | -26.9% | Jun 28, 2022 |
| Morgan Stanley | Simeon Gutman | $2,420 | $2,013.81 | -23.0% | Jun 16, 2022 |
| Stephens | Analyst unavailable | $2,285 | $1,964.66 | -27.3% | May 26, 2022 |
| Truist Financial | Scot Ciccarelli | $2,174 | $1,928.31 | -30.8% | May 25, 2022 |
| D.A. Davidson | Analyst unavailable | $1,920 | $1,938.13 | -38.9% | May 25, 2022 |
| Raymond James | Analyst unavailable | $2,400 | $2,175.95 | -23.6% | Apr 19, 2022 |
| Citigroup | Steven Zaccone | $2,210 | $1,878.77 | -29.7% | Mar 2, 2022 |
| UBS | Michael Lasser | $2,100 | $1,951.16 | -33.2% | Jan 28, 2022 |
| D.A. Davidson | Michael Baker | $2,100 | $2,084.52 | -33.2% | Dec 30, 2021 |
| Oppenheimer | Brian Nagel | $2,500 | $1,965.83 | -20.4% | Dec 9, 2021 |
| Wedbush | Seth Basham | $2,250 | $1,988.86 | -28.4% | Dec 8, 2021 |
| Goldman Sachs | Kate McShane | $2,045 | $1,988.86 | -34.9% | Dec 8, 2021 |
| Stephens | Daniel Imbro | $2,210 | $1,988.86 | -29.7% | Dec 8, 2021 |
| CFRA | Garrett Nelson | $1,925 | $1,911.84 | -38.7% | Nov 15, 2021 |
| Bank of America Securities | Elizabeth Lane Suzuki | $1,490 | $1,683.76 | -52.6% | Sep 22, 2021 |
| Credit Suisse | Lavesh Hemnani | $1,785 | $1,683.76 | -43.2% | Sep 22, 2021 |
Track every rating change on AZO the moment it posts. Free to start.
Start free